Bigane
20-10-2013, 05:06 AM
A very interesting turnaround story. After doing not a lot over the past few years, the Board and management underwent a major restructure in Feb 2013. They now have an experienced management team with a marketing focus.
Consegna Group Ltd (Soon to be re-named Rhinomed) is a respiratory technology company that is about to launch its first product 'The Turbine' onto the market in mid November. The turbine is a nasal dialator that increases airflow to the lungs by 38%. Some are describing it as the next generation of Breathe Right nasal strips.
The first target market is performance athletes via online sales. The team is also looking at applications for snoring, sleep apnea, and drug delivery for future product launches.
While there is a chance that market take-up will be slow, margins on the Turbines are high (cost of production per unit is less than $1 and the sales price is approx AUD$25 for a 3 pack) and coming off a low market cap (currently AUD$16.5m), I think there could be a lot of upside.
http://www.rhinomed.com.au/about-rhino-med
I would be interested to know others thoughts on this company.
Consegna Group Ltd (Soon to be re-named Rhinomed) is a respiratory technology company that is about to launch its first product 'The Turbine' onto the market in mid November. The turbine is a nasal dialator that increases airflow to the lungs by 38%. Some are describing it as the next generation of Breathe Right nasal strips.
The first target market is performance athletes via online sales. The team is also looking at applications for snoring, sleep apnea, and drug delivery for future product launches.
While there is a chance that market take-up will be slow, margins on the Turbines are high (cost of production per unit is less than $1 and the sales price is approx AUD$25 for a 3 pack) and coming off a low market cap (currently AUD$16.5m), I think there could be a lot of upside.
http://www.rhinomed.com.au/about-rhino-med
I would be interested to know others thoughts on this company.